cisplatin + cyclophosphamide + gemcitabine + goserelin

This is a combination chemotherapy and hormonal therapy regimen comprising four distinct agents. **Cisplatin** is a platinum-based chemotherapy agent that forms DNA crosslinks, inhibiting DNA replication and transcription. **Cyclophosphamide** is an alkylating agent that also damages DNA by forming crosslinks. **Gemcitabine** is a nucleoside analog antimetabolite that inhibits DNA synthesis. **Goserelin** is a gonadotropin-releasing hormone (GnRH) agonist that suppresses ovarian function by reducing estrogen production. This combination would theoretically provide cytotoxic chemotherapy effects through multiple mechanisms (platinum-based, alkylating, and antimetabolite) along with hormonal suppression, though this specific four-drug combination does not appear to be a standard established regimen in clinical practice.